These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29792750)

  • 1. Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices".
    Rodbard D
    Diabetes Technol Ther; 2018 May; 20(5):325-334. PubMed ID: 29792750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.
    Rodbard D; Bailey T; Jovanovic L; Zisser H; Kaplan R; Garg SK
    Diabetes Technol Ther; 2009 Nov; 11(11):717-23. PubMed ID: 19905888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating quality of glycemic control: graphical displays of hypo- and hyperglycemia, time in target range, and mean glucose.
    Rodbard D
    J Diabetes Sci Technol; 2015 Jan; 9(1):56-62. PubMed ID: 25316714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?
    Fabris C; Patek SD; Breton MD
    J Diabetes Sci Technol; 2015 Aug; 10(1):50-9. PubMed ID: 26275643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control.
    Rodbard D
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S55-67. PubMed ID: 19469679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
    Zueger T; Diem P; Mougiakakou S; Stettler C
    Diabetes Technol Ther; 2012 Jul; 14(7):583-8. PubMed ID: 22512266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study.
    Vehi J; Regincós Isern J; Parcerisas A; Calm R; Contreras I
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11933. PubMed ID: 30843865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent Exposure to Hypoglycemia Increases Glucose Variability Following a Hyper/Hypoglycemic Metabolic Challenge in T1D.
    Fabris C; Farhy LS; Anderson SM; Nass RM; Kovatchev BP; Breton MD
    J Diabetes Sci Technol; 2018 Mar; 12(2):311-317. PubMed ID: 28942668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Average Daily Risk Range as a Measure of Glycemic Variability in Youths with Type 1 Diabetes.
    Patton SR; DeLurgio SA; Clements MA
    Diabetes Technol Ther; 2015 Nov; 17(11):795-800. PubMed ID: 26535929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new measure of blood glucose variability in diabetes.
    Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
    Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypo- and Hyperglycemic Alarms: Devices and Algorithms.
    Howsmon D; Bequette BW
    J Diabetes Sci Technol; 2015 Apr; 9(5):1126-37. PubMed ID: 25931581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.
    Gómez AM; Muñoz OM; Marin A; Fonseca MC; Rondon M; Robledo Gómez MA; Sanko A; Lujan D; García-Jaramillo M; León Vargas FM
    J Diabetes Sci Technol; 2018 Sep; 12(5):1007-1015. PubMed ID: 29451006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution.
    Rodbard D
    Diabetes Technol Ther; 2012 Oct; 14(10):868-76. PubMed ID: 22953755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
    McCall AL; Cox DJ; Crean J; Gloster M; Kovatchev BP
    Diabetes Technol Ther; 2006 Dec; 8(6):644-53. PubMed ID: 17109596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Weinger K; Jacobson AM; Draelos MT; Finkelstein DM; Simonson DC
    Am J Med; 1995 Jan; 98(1):22-31. PubMed ID: 7825615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy.
    Rodbard D
    Diabetes Technol Ther; 2021 Oct; 23(10):692-704. PubMed ID: 34086495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.